ArticleCancer biomarkers : section A of Disease markers2020

Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.

Laura C Hurley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.